Package 62032-612-04

Brand: clenziderm pore therapy acne treatment

Generic: salicylic acid
NDC Package

Package Facts

Identity

Package NDC 62032-612-04
Digits Only 6203261204
Product NDC 62032-612
Description

148 mL in 1 BOTTLE, PLASTIC (62032-612-04)

Marketing

Marketing Status
Marketed Since 2007-02-01
Brand clenziderm pore therapy acne treatment
Generic salicylic acid
Sample Package No

Linked Drug Pages (3)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "7a1227cd-1bd0-4952-ae9e-d03d7c911b58", "openfda": {"unii": ["O414PZ4LPZ"], "rxcui": ["251577", "1235208"], "spl_set_id": ["08c1a55e-a376-4cd6-896f-0ad2068a1fc0"], "manufacturer_name": ["Obagi Cosmeceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "148 mL in 1 BOTTLE, PLASTIC (62032-612-04)", "package_ndc": "62032-612-04", "marketing_start_date": "20070201"}], "brand_name": "CLENZIDERM PORE THERAPY ACNE TREATMENT", "product_id": "62032-612_7a1227cd-1bd0-4952-ae9e-d03d7c911b58", "dosage_form": "LIQUID", "product_ndc": "62032-612", "generic_name": "SALICYLIC ACID", "labeler_name": "Obagi Cosmeceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "CLENZIDERM PORE THERAPY", "brand_name_suffix": "ACNE TREATMENT", "active_ingredients": [{"name": "SALICYLIC ACID", "strength": "20 mg/mL"}], "application_number": "M006", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20070201", "listing_expiration_date": "20261231"}